Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

--------------------------------------------------------------------
Source: Guardian Australia
Published: 2026-04-11 05:55 UTC+10:00
Section: Ovarian cancer
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant cases
--------------------------------------------------------------------
>>> Read full article at Guardian Australia <<<
<-- Back to Home
< >
[Close]